Menu
Log in
Forgot password



Your Resource for Neurotherapeutics Discovery and Development


Log in
  • Home
  • Annual Meeting

Annual Meeting Overview

BECOME A SUPPORTER DOWNLOAD THE ADVANCE PROGRAM SUBMIT AN ABSTRACT REGISTER TO ATTEND


Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2025) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 12-14, 2025. 

ASENT's 2025 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features 12 symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

2025 Meeting Highlights 

    • 12 - 16 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
    • DEBATE: Featuring a hot topic and current data
    • CNS PIPELINE Presentations
    • CAREER DINNER Featuring Guest Speakers
    • Interactive Poster Discussions
    • Sponsored Symposia from Innovation Leaders
    • Live Discussions in Breakout Rooms with Speakers
    • 2nd Annual Neurotherapeutics Clinical Trial Course - LIVE  (application only)


    This year our program will include symposia on:

    • Gene targeted therapy for Epilepsy
    • Universal Framework for Staging of Neurodegenerative Diseases
    • A Broader Look at Patient Focused Drug Development
    • Immunotherapy of Neurodegenerative Disorders
    • An Update on Pediatric Neurotherapeutics
    • Novel Therapies in Duchenne and Becker’s Muscular Dystrophy
    • Global Neuroinfectious Disease
    • Autoimmune Therapeutics presented inconjunction with the Japanese Society of Neurological Therapeutics
    • Diversity and Equity in Clinical Trials
    • ”Tell me about it” speech analysis in Neurodegenerative Diseases
    • Update on Pain Therapeutic Opportunities
    • Updates in Neurovascular and Stroke Therapeutics
    • Interactive Poster Discussions
    • Dynamic Pipeline Presentations
    • Live Discussions in Breakout Rooms with Speakers
    • And much, much more!


    Popular Sessions from 2024 Meeting 

    • FIRESIDE CHAT: Preclinical to First in Human in Neurotherapeutic Drug Development
    • Platform Clinical Trials in Neurology Featuring speakers from FDA and Biohaven
    • Exosome in Neurotherapeutics
    • Digital Biomarkers in CNS Clinical Studies
    • Opportunities to streamline development of gene therapies for rare diseases featuring speakers from FDA and Eli Lilly
    • Current research and Advances in Multiple Sclerosis
    • Parkinson's disease biological staging and implications for therapeutic trials
    • Fluid Biomarkers as endpoints for neurodegenerative diseases
    • Animal Models in Neurotherapeutics: the good, the bad and the ugly.
    • Novel Delivery Systems in CNS

    Meeting Location
    Hyatt Regency Bethesda, Bethesda MD

    LINK AVAILABLE SOON

    Who Attends

    50% of attendees are practicing physicians| Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2025 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at a discounted cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 


    Upcoming events

    • ASENT 2025 Clinical Trials Course

      • March 10, 2025
      • March 11, 2025
      • Hyatt Regency Bethesda, Bethesda MD

      Training in Neurotherapeutic Clinical Trials: Development and Implementation Course

      APPLICATION DEADLINE EXTENDED: NOVEMBER 19, 2024

      APPLY TODAY

      DOWNLOAD THE BROCHURE

      About the Course

      • Format: In Person 
      • Application: Free 
      • Tuition: $450 for Accepted Applicants 
      • Requirements: Completed Application 
      • Credentials Provided: Certificate of Completion 
      • Included: Course materials, Discounted Registration for ASENT Annual Meeting, Discounted fee to Submit Abstract to ASENT. 
      • Not Included: Travel and Hotel is not included for all participants

      ASENT is pleased to offer a 2-day course March 10-11, 2025 at the Hyatt Regency Bethesda, in Bethesda, MD to introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation. The course will be especially relevant if you are interested in conducting neurotherapeutic clinical trials.

      The course covers the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The course will also address the unique challenges inherent in developing treatments for nervous system disorders. 

      The course will feature a mix of:

      • Didactic sessions that go in depth into a wide range of topics

      • Interactive workshops where participants will work in teams on projects such as drafting protocols and addressing adverse events 

      • Panel discussions with lively Q&A 

      • Discounted access to the ASENT Annual Meeting

      APPLY TODAY

      DOWNLOAD THE BROCHURE


      Participants who attend the course will have ongoing access to senior faculty in attendance in a mentoring capacity. We anticipate that most applicants will have some familiarity with clinical research however, any clinical investigator who would benefit from the course is invited to apply. Those in industry and in private practice are also welcome to apply. The course will be offered annually and participants have discounted access to the ASENT Annual Meeting.

      You will be asked to provide:

      • Name
      • Contact Information
      • CV
      • A one page letter of interest

      We are excited to have the opportunity to offer this course, which we believe will help to advance the availability of new drugs for patients with neurological conditions. If your work would benefit from an understanding of neurologic clinical trials you are encouraged to apply.

      APPLY TODAY

      DOWNLOAD THE BROCHURE


      Show details

    • ASENT 2025 Annual Meeting

      • March 12, 2025
      • 8:00 AM
      • March 14, 2025
      • 1:00 PM
      • Hyatt Regency Bethesda, Bethesda, MD
      Register

      ABOUT ASENT 2025 Annual Meeting

      The ASENT 2025 Annual Meeting, which will take place March 12 - 14, 2025 at the Hyatt Regency Bethesda in Bethesda, MD, is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

      The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

      WHO ATTENDS

      Physician-Scientists | Neurologists | Neuroscientists | Trainees | Drug and Device Companies | CROs | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA


      Show details
    Powered by Wild Apricot Membership Software